There is still a lot of research devoted to this compound(SMILES:O[C@H]([C@H]([C@H]([C@@H](CO)O1)O)O)[C@@H]1OC)Recommanded Product: (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol, and with the development of science, more effects of this compound(1824-94-8) can be discovered.
The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol, is researched, Molecular C7H14O6, CAS is 1824-94-8, about Lactobacillus acidophilus LA14 Alleviates Liver Injury, the main research direction is Lactobacillus liver injury serum alanine aspartate aminotransferase ALP; Lactobacillus acidophilus; acute liver injury; metabolome; microbiota; transcriptome.Recommanded Product: (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol.
Although the probiotic Lactobacillus acidophilus LA14 is used worldwide, its effect on liver diseases remains unelucidated. Here, 32 rats were divided into four groups, gavaged with L. acidophilus LA14 (3 x 109 CFU) or phosphate-buffered saline for 7 days, and then i.p. injected with D-galactosamine or saline. After 24 h, blood, liver, ileum, and feces samples were collected for liver injury, inflammation, intestinal barrier, gut microbiota, metabolome, and transcriptome analyses. Pretreatment with L. acidophilus LA14 alleviated the D-galactosamineinduced elevation of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alk. phosphatase (ALP), and bile acids; mitigated the histol. injury to the liver and gut; and suppressed the inflammatory cytokines macrophage inflammatory protein 1a (MIP-1a), MIP-3a, and MCP-1. L. acidophilus LA14 also ameliorated the D-galactosamine-induced dysbiosis of the gut microbiota and metabolism, such as the enrichment of Bacteroides sp. strain dnLKV3 and the depletion of Streptococcus, butanoic acid, and N-acetyl-D-glucosamine. The underlying mechanism of L. acidophilus LA14 included prevention of not only the D-galactosamine-induced upregulation of infectionand tumor-related pathways but also the D-galactosamine-induced downregulation of antioxidation-related pathways during this process, as reflected by the liver transcriptome and proteome analyses. Furthermore, the administration of L. acidophilus LA14 to healthy rats did not alter the tested liver indicators but significantly enriched the beneficial Lactobacillus and Bifidobacterium species, promoted metabolism and regulated pathways to improve immunity. The ability of L. acidophilus LA14 to alleviate liver injury was further confirmed with an acetaminophen-induced mouse model. These results might provide a reference for future studies on the application of L. acidophilus LA14 for the prevention of liver injury.
There is still a lot of research devoted to this compound(SMILES:O[C@H]([C@H]([C@H]([C@@H](CO)O1)O)O)[C@@H]1OC)Recommanded Product: (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol, and with the development of science, more effects of this compound(1824-94-8) can be discovered.
Reference:
Phosphine ligand,
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate